AKER HAZEL M
Insider CIK 1265783 · ONCT Legal Counsel · CADX SVP, GC & Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-07-21 | 2020-07-23 | 20,986 | $2.38 | $49.9K | 20,986 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2020-07-21 | 2020-07-23 | 41,972 | $2.38 | $99.9K | 46,987 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-07-31 | 11,080 | — | $0 | 11,080 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-07-31 | 11,080 | — | $0 | 11,080 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-07-31 | 11,080 | — | $0 | 11,080 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-03-17 | 2020-03-18 | 11,080 | — | $0 | 11,080 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2020-07-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2019-09-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ONCT GTX INC /DE/ | A Award deriv | 2019-06-07 | 2019-06-11 | 140 | — | $0 | 140 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 4,284 | — | $0 | 4,284 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 5,015 | — | $0 | 5,015 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 200,000 | $4.78 | $956.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 125,000 | $8.60 | $1.07M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 321 | $10.49 | $3.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 109,451 | $10.49 | $1.15M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 80,000 | $5.45 | $436.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 120,000 | $14.00 | $1.68M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 15,000 | $4.78 | $71.7K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 70,000 | $5.65 | $395.5K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 65,000 | $7.99 | $519.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 150,000 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 3,745 | $14.00 | $52.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2014-02-10 | 2014-02-12 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-12-16 | 2013-12-18 | 13,014 | — | $0 | 109,451 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-12-16 | 2013-12-18 | 13,014 | $8.76 | $114.0K | 3,745 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-12-16 | 2013-12-18 | 13,014 | $3.51 | $45.7K | 16,759 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-11-15 | 2013-11-18 | 19,521 | — | $0 | 321 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-11-15 | 2013-11-18 | 32,535 | — | $0 | 122,465 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-11-15 | 2013-11-18 | 26,028 | $7.81 | $203.3K | 29,773 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-11-15 | 2013-11-18 | 26,028 | $7.00 | $182.2K | 3,745 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-11-15 | 2013-11-18 | 52,056 | $3.51 | $182.7K | 55,801 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-07-22 | 2013-07-23 | 6,507 | — | $0 | 19,842 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-07-22 | 2013-07-23 | 6,507 | $7.81 | $50.8K | 3,745 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-07-22 | 2013-07-23 | 6,507 | $3.51 | $22.8K | 10,252 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-07-15 | 2013-07-17 | 6,508 | — | $0 | 26,349 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-07-15 | 2013-07-17 | 6,508 | $7.34 | $47.8K | 3,745 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-07-15 | 2013-07-17 | 6,508 | $3.51 | $22.8K | 10,253 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2013-03-13 | 2013-03-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 32,857 | — | $0 | 32,857 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 155,000 | — | $0 | 155,000 | SEC↗ |